Literature DB >> 32209433

Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding.

Chiara Orlandi1, Daniel Deredge2, Krishanu Ray1, Neelakshi Gohain1, William Tolbert1, Anthony L DeVico1, Patrick Wintrode2, Marzena Pazgier1, George K Lewis3.   

Abstract

Antibody structure couples adaptive and innate immunity via Fab (antigen binding) and Fc (effector) domains that are connected by unique hinge regions. Because antibodies harbor two or more Fab domains, they are capable of crosslinking multi-determinant antigens, which is required for Fc-dependent functions through associative interactions with effector ligands, including C1q and cell surface Fc receptors. The modular nature of antibodies, with distal ligand binding sites for antigen and Fc-ligands, is reminiscent of allosteric proteins, suggesting that allosteric interactions might contribute to Fc-mediated effector functions. This hypothesis has been pursued for over 40 years and remains unresolved. Here, we provide evidence that allosteric interactions between Fab and Fc triggered by antigen binding modulate binding of Fc to low-affinity Fc receptors (FcγR) for a human IgG1. This work opens the path to further dissection of the relative roles of allosteric and associative interactions in Fc-mediated effector functions.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fc receptor binding; Fc-effector function; HDX-MS; IgG1 LALA variants; RFADCC Assay; antigen binding; configurational allostery; conformational allostery; immunoglobulin

Mesh:

Substances:

Year:  2020        PMID: 32209433      PMCID: PMC7288244          DOI: 10.1016/j.str.2020.03.001

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  82 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  A variant human IgG1-Fc mediates improved ADCC.

Authors:  Ross Stewart; George Thom; Michaela Levens; Gülin Güler-Gane; Robert Holgate; Pauline M Rudd; Carl Webster; Lutz Jermutus; John Lund
Journal:  Protein Eng Des Sel       Date:  2011-05-18       Impact factor: 1.650

3.  Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1.

Authors:  M Hezareh; A J Hessell; R C Jensen; J G van de Winkel; P W Parren
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen.

Authors:  Guanbo Wang; Rob N de Jong; Ewald T J van den Bremer; Frank J Beurskens; Aran F Labrijn; Deniz Ugurlar; Piet Gros; Janine Schuurman; Paul W H I Parren; Albert J R Heck
Journal:  Mol Cell       Date:  2016-06-16       Impact factor: 17.970

5.  Hapten-induced allosteric transition in the light chain dimer of an immunoglobulin.

Authors:  D Lancet; A Licht; I Schechter; I Pecht
Journal:  Nature       Date:  1977-10-27       Impact factor: 49.962

6.  Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.

Authors:  Neelakshi Gohain; William D Tolbert; Priyamvada Acharya; Lei Yu; Tongyun Liu; Pingsen Zhao; Chiara Orlandi; Maria L Visciano; Roberta Kamin-Lewis; Mohammad M Sajadi; Loïc Martin; James E Robinson; Peter D Kwong; Anthony L DeVico; Krishanu Ray; George K Lewis; Marzena Pazgier
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

7.  Antigenic properties of the HIV envelope on virions in solution.

Authors:  Krishanu Ray; Meron Mengistu; Lei Yu; George K Lewis; Joseph R Lakowicz; Anthony L DeVico
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

8.  Solving structures of protein complexes by molecular replacement with Phaser.

Authors:  Airlie J McCoy
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-12-13

9.  Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells.

Authors:  Meron Mengistu; Krishanu Ray; George K Lewis; Anthony L DeVico
Journal:  PLoS Pathog       Date:  2015-03-25       Impact factor: 6.823

Review 10.  Ig Constant Region Effects on Variable Region Structure and Function.

Authors:  Alena Janda; Anthony Bowen; Neil S Greenspan; Arturo Casadevall
Journal:  Front Microbiol       Date:  2016-02-04       Impact factor: 5.640

View more
  5 in total

Review 1.  Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems.

Authors:  Ellie I James; Taylor A Murphree; Clint Vorauer; John R Engen; Miklos Guttman
Journal:  Chem Rev       Date:  2021-09-07       Impact factor: 72.087

2.  Non-covalent Fc-Fab interactions significantly alter internal dynamics of an IgG1 antibody.

Authors:  Ramakrishnan Natesan; Neeraj J Agrawal
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

3.  Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies.

Authors:  Laura E Doepker; Sonja Danon; Elias Harkins; Duncan K Ralph; Zak Yaffe; Meghan E Garrett; Amrit Dhar; Cassia Wagner; Megan M Stumpf; Dana Arenz; James A Williams; Walter Jaoko; Kishor Mandaliya; Kelly K Lee; Frederick A Matsen; Julie M Overbaugh
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

4.  The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa.

Authors:  Yuki Yamaguchi; Natsumi Wakaizumi; Mine Irisa; Takahiro Maruno; Mari Shimada; Koya Shintani; Haruka Nishiumi; Rina Yogo; Saeko Yanaka; Daisuke Higo; Tetsuo Torisu; Koichi Kato; Susumu Uchiyama
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

5.  Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Authors:  Bruce D Wines; Liriye Kurtovic; Halina M Trist; Sandra Esparon; Ester Lopez; Klasina Chappin; Li-Jin Chan; Francesca L Mordant; Wen Shi Lee; Nicholas A Gherardin; Sheila K Patel; Gemma E Hartley; Phillip Pymm; James P Cooney; James G Beeson; Dale I Godfrey; Louise M Burrell; Menno C van Zelm; Adam K Wheatley; Amy W Chung; Wai-Hong Tham; Kanta Subbarao; Stephen J Kent; P Mark Hogarth
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.